161 related articles for article (PubMed ID: 21087528)
1. p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell.
Wei J; Zhao J; Long M; Han Y; Wang X; Lin F; Ren J; He T; Zhang H
BMC Cancer; 2010 Nov; 10():632. PubMed ID: 21087528
[TBL] [Abstract][Full Text] [Related]
2. Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation.
Hu J; Chen Z; Xia D; Wu J; Xu H; Ye ZQ
Biochem J; 2012 Nov; 447(3):407-16. PubMed ID: 23035981
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
[TBL] [Abstract][Full Text] [Related]
4. Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.
Kosaka M; Kang MR; Yang G; Li LC
Nucleic Acid Ther; 2012 Oct; 22(5):335-43. PubMed ID: 22909100
[TBL] [Abstract][Full Text] [Related]
5. Small double-stranded RNA mediates the anti-cancer effects of p21WAF1/ClP1 transcriptional activation in a human glioma cell line.
Dong Z; Dang Y; Chen Y
Yonsei Med J; 2014 Mar; 55(2):324-30. PubMed ID: 24532499
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of p21WAF1/CIP1 by small activating RNA inhibits the in vitro and in vivo growth of pancreatic cancer cells.
Zhang Z; Wang Z; Liu X; Wang J; Li F; Li C; Shan B
Tumori; 2012 Nov; 98(6):804-11. PubMed ID: 23389370
[TBL] [Abstract][Full Text] [Related]
7. Demystifying the mechanistic and functional aspects of p21 gene activation with double-stranded RNAs in human cancer cells.
Wu HL; Li SM; Hu J; Yu X; Xu H; Chen Z; Ye ZQ
J Exp Clin Cancer Res; 2016 Sep; 35(1):145. PubMed ID: 27639690
[TBL] [Abstract][Full Text] [Related]
8. Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells.
Li C; Ge Q; Liu J; Zhang Q; Wang C; Cui K; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317710824. PubMed ID: 28631573
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
[TBL] [Abstract][Full Text] [Related]
10. The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells.
Lincet H; Poulain L; Remy JS; Deslandes E; Duigou F; Gauduchon P; Staedel C
Cancer Lett; 2000 Dec; 161(1):17-26. PubMed ID: 11078909
[TBL] [Abstract][Full Text] [Related]
11. Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells.
Qin LF; Ng IO
Cancer Lett; 2001 Oct; 172(1):7-15. PubMed ID: 11595124
[TBL] [Abstract][Full Text] [Related]
12. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
[TBL] [Abstract][Full Text] [Related]
13. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
[TBL] [Abstract][Full Text] [Related]
15. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
16. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
17. A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate.
Kraljevic Pavelic S; Cacev T; Kralj M
Cancer Gene Ther; 2008 Sep; 15(9):576-90. PubMed ID: 18483502
[TBL] [Abstract][Full Text] [Related]
18. Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21(WAF1/CIP1 ).
Mu YM; Oba K; Yanase T; Ito T; Ashida K; Goto K; Morinaga H; Ikuyama S; Takayanagi R; Nawata H
Endocr J; 2003 Dec; 50(6):771-81. PubMed ID: 14709851
[TBL] [Abstract][Full Text] [Related]
19. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p21Waf1/Cip1 cleavage during roscovitine-induced apoptosis in non-small cell lung cancer cells.
Zhang T; Jiang T; Zhang F; Li C; Zhou YA; Zhu YF; Li XF
Oncol Rep; 2010 Jan; 23(1):239-45. PubMed ID: 19956888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
